Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica

NCT01220180 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.

NCT NCT01220180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
April 30, 2011
Enrollment
4,175 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, fibromyalgia, neuropathic pain, post-market surveillance